The report showed the amount of million-dollar-plus claims increased by 25 percent since last year.
Here are the top 10 costliest medical conditions for 2016 ranked by value of stop-loss claims reimbursements:
- Malignant neoplasm (cancer) —$429.5 million
- Leukemia/lymphoma/multiple myeloma — $188.6 million
- Chronic/end-stage renal disease — $156.6 million
- Congenital Anomalies — $96.3 million
- Disorders relating to short gestation and low birth weight — $75.2 million
- Transplant — $62.2 million
- Congestive heart failure — $57.8 million
- Cerebrovascular disease (brain blood vessels) — $57.4 million
- Pulmonary collapse/respiratory failure — $55.0 million
- Septicemia (infection) — $54.7 million
More articles on supply chain:
Olympus to break ground on service center in Tennessee
Three priorities for every healthcare supply chain leader
FDA Commissioner: US needs improved system to track medical device issues
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
